Cate Brandon’s practice focuses on the intersection of healthcare law and policy. Ms. Brandon counsels life sciences companies, healthcare providers, and related trade and specialty societies on healthcare regulatory, compliance and enforcement matters, as well as public policy issues. Ms. Brandon’s work includes advising pharmaceutical companies and healthcare providers on matters related to healthcare fraud and abuse compliance, including anti-kickback laws and the “Stark” physician self-referral law; Medicare and Medicaid reimbursement and related policies, including the Inflation Reduction Act; the Patient Protection and Affordable Care Act (ACA); the No Surprises Act; and other regulatory and legislative initiatives affecting the life sciences and healthcare industries. Ms. Brandon has particular experience advising clients on patient support programs, contractual arrangements, value-based arrangements and reimbursement, digital health initiatives, and industry collaborations.